Literature DB >> 35156158

Gangliosides in T cell development and function of mice.

Jin-Ichi Inokuchi1,2, Masakazu Nagafuku3.   

Abstract

The molecular diversity of glycosphingolipids (GSLs) that arouse during the course of evolution clearly plays an essential role in maintenance of biological homeostasis. Why is such a wide variety of GSLs necessary, and what gave rise to the expression mechanisms that are selective and specific to individual cells, tissues, or organs? What is the biological significance of these mechanisms? The same questions apply to GSLs involved in T cell development and activation. Primary CD4+ T cells and CD8+ T cells preferentially express differing ganglioside series: a-series and o-series, respectively. Conversely, a-series and o-series ganglioside deficiency results respectively in CD4+ and CD8+ T cell dysfunction. Dynamic changes in ganglioside expression occur during T cell development in thymus. Ganglioside GM3 synthase deficiency, which results in lack of a-series gangliosides, ameliorated CD4+ T cell-mediated airway hypersensitivity in a mouse model of allergic asthma. In this review, we summarize findings from these and many studies to illustrate the key roles of gangliosides in T cell differentiation and function.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CD4 + T cell; CD8 + T cell; D-PDMP; Gangliosides; Immunological synapse; Lipid raft; T cell receptor (TCR)

Mesh:

Substances:

Year:  2022        PMID: 35156158     DOI: 10.1007/s10719-021-10037-5

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  51 in total

Review 1.  Glucosphingolipids as sites of action in the chemotherapy of cancer.

Authors:  N S Radin; J Inokuchi
Journal:  Biochem Pharmacol       Date:  1988-08-01       Impact factor: 5.858

2.  Dissociation of the insulin receptor from caveolae during TNFα-induced insulin resistance and its recovery by D-PDMP.

Authors:  Junji Sekimoto; Kazuya Kabayama; Kazutoshi Gohara; Jin-ichi Inokuchi
Journal:  FEBS Lett       Date:  2011-12-22       Impact factor: 4.124

3.  Glucosylceramide synthetase inhibitor, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol exhibits a novel decarcinogenic activity against Shope carcinoma cells.

Authors:  M Kyogashima; M Inoue; A Seto; J Inokuchi
Journal:  Cancer Lett       Date:  1996-03-19       Impact factor: 8.679

4.  A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis.

Authors:  B Felding-Habermann; Y Igarashi; B A Fenderson; L S Park; N S Radin; J Inokuchi; G Strassmann; K Handa; S Hakomori
Journal:  Biochemistry       Date:  1990-07-03       Impact factor: 3.162

5.  Effects of glucosylceramide synthase inhibitor and ganglioside GQ1b on synchronous oscillations of intracellular Ca2+ in cultured cortical neurons.

Authors:  A Mizutani; Y Kuroda; K Muramoto; K Kobayashi; K Yamagishi; J Inokuchi
Journal:  Biochem Biophys Res Commun       Date:  1996-05-15       Impact factor: 3.575

6.  Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells.

Authors:  J Inokuchi; K Momosaki; H Shimeno; A Nagamatsu; N S Radin
Journal:  J Cell Physiol       Date:  1989-12       Impact factor: 6.384

7.  Ganglioside GM3 participates in the pathological conditions of insulin resistance.

Authors:  Seiichi Tagami; Jin-ichi Inokuchi Ji; Kazuya Kabayama; Haruhiko Yoshimura; Futoshi Kitamura; Satoshi Uemura; Chie Ogawa; Atsushi Ishii; Masaki Saito; Yoshinori Ohtsuka; Shinji Sakaue; Yasuyuki Igarashi
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

8.  Reduction of glycosphingolipid levels in lipid rafts affects the expression state and function of glycosylphosphatidylinositol-anchored proteins but does not impair signal transduction via the T cell receptor.

Authors:  Masakazu Nagafuku; Kazuya Kabayama; Daisuke Oka; Akiko Kato; Shizue Tani-ichi; Yukiko Shimada; Yoshiko Ohno-Iwashita; Sho Yamasaki; Takashi Saito; Kazuya Iwabuchi; Toshiyuki Hamaoka; Jin-ichi Inokuchi; Atsushi Kosugi
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

9.  Glucosylceramide synthase inhibitor inhibits the action of nerve growth factor in PC12 cells.

Authors:  T Mutoh; A Tokuda; J Inokuchi; M Kuriyama
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

10.  Rapid kidney changes resulting from glycosphingolipid depletion by treatment with a glucosyltransferase inhibitor.

Authors:  G S Shukla; A Shukla; J Inokuchi; N S Radin
Journal:  Biochim Biophys Acta       Date:  1991-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.